Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_658df3b9d24eb5224b37aaf605741db6 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- |
filingDate |
2010-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f84029b206c42810f901ab35848c68d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a41c9df8eee0cf737ac497117d374ffd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4173fe41ee9ea06c27fcee95b48bcd43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09827e7a119718a3296e5eaafdfe62a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a311e045193413f4144fc549863961be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_599e162ac9d241e38aa2948160e44e78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f630e9fd331d2cff828fa4ce73106546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02b2721d0cbb8f7bdc5fd874125c029b |
publicationDate |
2015-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
IN-2012DN00377-A |
abstract |
ABSTRACT Glucagon peptides with increased GIP activity are provided optionally with GLP-I and/or glucagon activity. In some embodiments C-terminally extended glucagon peptides comprising an amino acid sequence substantially similar to native glucagon are provided herein. |
priorityDate |
2009-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |